Aptar CSP Technologies, part of AptarGroup, has announced the expansion of its service offerings with the launch of a cGMP-compliant manufacturing facility in New Jersey.
Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s fixed-dose triple-combination therapy Breztri Aerosphere met all primary endpoints.
PCI Pharma Services, a global contract development and manufacturing organisation (CDMO) focused on innovative biopharma therapies, has completed its acquisition of Ajinomoto Althea.
Identiv and InPlay, a wireless System-on-Chip (SoC) solution provider, has announced the co-development of a new portfolio of BLE-enabled smart labels designed for high-value logistics applications.
Lineage Cell Therapeutics, a clinical-stage biotechnology company, has announced that the Company has initiated the DOSED (Delivery of Oligodendrocyte Progenitor Cells (OPCs) for Spinal Cord Injury: Evaluation of a Novel Device) clinical study.
NETZSCH Pumps & Systems announces the NEMO R. MY Magnetically Coupled Pump, a pump designed to meet the most demanding requirements of industries requiring leak-free pumping solutions.
August 2025 marks two years since revisions to Annex 1 of the European Union’s Good Manufacturing Practice (GMP) guidelines were introduced. Niamh Bissett, director, business transformation at West Pharmaceutical Services discusses.
